
Injective (INJ) price has entered a decisive phase after spending several weeks consolidating beneath the $5.55–$5.60 resistance zone. The token has consistently formed higher lows while struggling to overcome overhead selling pressure, creating a tightening price structure that often precedes a significant move. With buyers gradually reclaiming lost ground and resistance facing repeated tests, traders are closely watching whether INJ can finally secure a breakout toward $6.08 or face another rejection.
Injective (INJ) has extended its recovery over the past few weeks, climbing from below $4.20 to around $5.38 as buyers steadily regained control. The rally has unfolded within a rising wedge pattern, with the token now approaching the crucial $5.55–$5.60 resistance zone that has capped upside since June. A decisive move beyond this level could strengthen bullish momentum and expose higher price targets, while another rejection may prolong the ongoing consolidation.
Injective (INJ) price remains in a constructive position as buyers continue defending higher support levels while challenging the multi-week resistance near $5.55. The narrowing price structure suggests a decisive move could be approaching, with a breakout likely to strengthen bullish momentum toward $6.08. Until that confirmation arrives, traders should watch whether buyers can sustain pressure above support or whether another rejection extends the ongoing consolidation.
On a corporate treasury desk, the question that once defined a good day was simple:…
Japan-listed digital asset treasury company Remixpoint has sold all of its ETH, XRP, SOL and…
Story Highlights Bitcoin is currently trading at: Bitcoin holds strong near $70K in 2026, signaling…
Japanese listed company Remixpoint offloaded its entire altcoin portfolio on September 1, selling roughly 901.45…
Joe Carlasare, commercial litigator, Bitcoin advocate and author of Unconfiscatable, said Bitcoin's recent dip below…
Uber Technologies will lay off about 3,300 employees, roughly 10% of its workforce, in a…